Evidence map›Paper›PMID 41703634›Full record

Trial reportJournal of neuroengineering and rehabilitation2026

Preventing slowing down of alpha rhythms in stroke patients through modulation of cortical excitatory-inhibitory balance: a randomized controlled trial.

Francisco Páscoa Dos Santos, Javier de la Torre Costa, Martina Maier, Belén Rubio Ballester, Maria Engracia Perez, Xavier Buxó, Maria Sueiras Gil, Vanessa Thonon, Anna Mura, Susana Rodriguez and 1 more

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of neuroengineering and rehabilitation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Francisco Páscoa Dos SantosEodyne Systems SL, Barcelona, Spain. f.pascoadossantos@gmail.com.
Javier de la Torre CostaLaboratory of Synthetic, Perceptive, Emotive and Cognitive Systems (SPECS), Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
Martina MaierLaboratory of Synthetic, Perceptive, Emotive and Cognitive Systems (SPECS), Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
Belén Rubio BallesterLaboratory of Synthetic, Perceptive, Emotive and Cognitive Systems (SPECS), Institute for Bioengineering of Catalonia (IBEC), Barcelona, Spain.
Maria Engracia PerezNeurorehabilitation Unit. Physical Medicine and Rehabilitation Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Xavier BuxóNeurorehabilitation Unit. Physical Medicine and Rehabilitation Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Maria Sueiras GilClinical Neurophysiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Vanessa ThononClinical Neurophysiology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Anna MuraSPECS-lab, CSIC Institute of Neuroscience, Department of Health Psychology, Universidad Miguel Hernandez de Elche - UMH, Alicante, Spain.
Susana RodriguezNeurorehabilitation Unit. Physical Medicine and Rehabilitation Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Paul VerschureSPECS-lab, CSIC Institute of Neuroscience, Department of Health Psychology, Universidad Miguel Hernandez de Elche - UMH, Alicante, Spain.

Funding

EIT Health 19277H2020 Marie Skłodowska-Curie Actions 860563Horizon 2020 Framework Programme 826421HORIZON EUROPE European Innovation Council 101058240HORIZON EUROPE European Research Council 101057655
6 · The paper itself

Abstract

Several procedures have been developed to enhance the rehabilitation of stroke patients. However, most techniques struggle to promote sustained recovery in the months following the treatment. Therefore, it is essential to understand the mechanisms that can be harnessed during treatment to potentiate retention of benefits and sustained recovery. While stroke patients often suffer from thalamocortical dysrhythmia (TCD), a perturbation in alpha (8-13 Hz) rhythms caused by decreased excitation in the cortico-thalamic projections, the functional relevance of TCD in stroke patients is not yet clear. We propose that TCD can be counteracted by combining focal stimulation of the motor cortex with virtual-reality (VR) based rehabilitation, which engages distributed networks associated with goal-oriented behavior. Critically, we investigate whether this can be the key to promoting sustained recovery in stroke patients. We compare thalamocortical rhythms and behavioral recovery in patients receiving Sham and bilateral tDCS stimulation of the motor cortex during therapy with the Rehabilitation Gaming System (RGS). Our results reveal that patients in the tDCS group show a sustained recovery in all clinical scales up to three months post-treatment, as opposed to the Sham group. Furthermore, we demonstrate that the slowing down of alpha rhythms can be counteracted by transcranial direct-current stimulation (tDCS), with a particular role for enhancing the excitability of parietal areas. That said, we found no correlation between changes in alpha rhythms and motor recovery. On one hand, our findings suggest that sustained recovery can be potentiated by tDCS-enhanced VR-based rehabilitation. On the other hand, enhancing the excitability of parietal areas while recruiting brain networks associated with goal-oriented behavior can successfully counteract TCD, even though this is likely not the main driver of sustained motor recovery.

Indexed as

Alpha RhythmMotor CortexStrokeStroke RehabilitationTranscranial Direct Current StimulationAgedFemaleHumansMaleMiddle AgedRecovery of FunctionAlpha rhythmsExcitatory-inhibitory balanceRehabilitationStrokeTranscranial direct-current stimulation

Identifiers

PMID41703634
PMCPMC13014810

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.